EUVIMEDEUVIMED entdecken
Open Access

Collagen Hybridizing Peptide–Based Radiotracers for Molecular Imaging of Collagen Turnover in Pulmonary Fibrosis

Azmi A Ahmad, Mean Ghim, Gunjan Kukreja, Afarin Neishabouri, Zhengxing Zhang, Jie Li, Mani Salarian, Jakub Toczek, Kiran Gona, Keshvad Hedayatyanfard, Tian Morrison, Jiasheng Zhang und 4 weitere

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.268832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Azmi A Ahmad und 15 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Collagen, Molecular Imaging, Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis is a characteristic feature of interstitial lung disease. Current clinical diagnostic methods provide a snapshot of the lung structure without information on disease activity. Collagen hybridizing peptides offer the opportunity to detect collagen remodeling through their hybridization with denatured collagen. Here, we sought to develop a 99mTc-labeled collagen hybridizing tracer to track denatured collagen in vivo and validate it in a murine model of pulmonary fibrosis.

Methods

Imaging agents consisting of a polyhistidine or a poly–histidine–glutamic acid [(HE)3] peptide connected to an N-terminal targeting moiety with 9 glycine–proline–hydroxyproline repeats [(GPO)9] through a 3-glycine linker were synthesized. After radiolabeling with 99mTc-tricarbonyl, the labeled products’ purity and stability were evaluated by high-performance liquid chromatography and γ-well counting, and their biodistributions were compared in mice. To induce pulmonary fibrosis, the lungs of 8- to 10-wk-old mice were exposed to bleomycin (or saline as control). At 3 wk after induction, SPECT/CT imaging with 99mTc-(HE)3-(GPO)9 was performed 1 h after injection and was followed by tissue collection to assess 99mTc-(HE)3-(GPO)9 biodistribution by γ-well counting and to evaluate lung histology. The specificity of the tracer uptake was assessed using a scrambled homolog. A group of animals underwent serial imaging 3 and 8–10 wk after induction.

Results

The specific activity of the final radiolabeled product was 70.3 ± 14.8 GBq/µmol. Radiolabeled tracers were stable in blood for at least 2 h and showed rapid blood clearance. 99mTc-(HE)3-(GPO)9 showed lower liver uptake in biodistribution studies and was selected for in vivo imaging studies. SPECT/CT imaging of bleomycin-treated mice 3 wk after induction showed higher specific 99mTc-(HE)3-(GPO)9 lung uptake than that of control mice (P < 0.01) and that of bleomycin-treated mice 8–10 wk after induction, when fibrosis was resolved (P < 0.05). There was a significant correlation between lung uptake quantified by SPECT/CT and γ-well counting (Pearson R = 0.83, P < 0.001) and significant correlations between tracer uptake and indices of tissue fibrosis. Conclusion:99mTc-(HE)3-(GPO)9 enables SPECT imaging of collagen turnover in pulmonary fibrosis. This approach expands the scope of existing diagnostic tools in fibrosis and can lead to better patient management by monitoring the effect of antifibrotic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisCollagenMolecular ImagingPeptidesRadiopharmaceuticalsAnimalsMiceTissue DistributionSingle Photon Emission Computed Tomography Computed TomographyRadioactive TracersBleomycin

Stichwörter der Autor:innen

SPECT/CTcollagenmolecular imagingpulmonary fibrosis

Substanzen

CollagenPeptidesRadioactive TracersRadiopharmaceuticalsBleomycin

Autor:innen und Institutionen

  • Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.
  • Department of Biomedical Engineering and Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah; and.
  • Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut.
  • Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; mehran.sadeghi@yale.edu.

Förderung

  • NCATS NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • BLRD VA

Zitieren

APA

Ahmad, A. A., Ghim, M., Kukreja, G., Neishabouri, A., Zhang, Z., Li, J., Salarian, M., Toczek, J., Gona, K., Hedayatyanfard, K., Morrison, T., Zhang, J., Huang, Y. H., Liu, C., Yu, S. M., & Sadeghi, M. M. (2025). Collagen Hybridizing Peptide–Based Radiotracers for Molecular Imaging of Collagen Turnover in Pulmonary Fibrosis. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268832

Vancouver

Ahmad AA, Ghim M, Kukreja G, Neishabouri A, Zhang Z, Li J, et al. Collagen Hybridizing Peptide–Based Radiotracers for Molecular Imaging of Collagen Turnover in Pulmonary Fibrosis. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268832

BibTeX
@article{Ahmad2025,
  author = {Ahmad, Azmi A and Ghim, Mean and Kukreja, Gunjan and Neishabouri, Afarin and Zhang, Zhengxing and Li, Jie and Salarian, Mani and Toczek, Jakub and Gona, Kiran and Hedayatyanfard, Keshvad and Morrison, Tian and Zhang, Jiasheng and Huang, Yiyun Henry and Liu, Chi and Yu, S Michael and Sadeghi, Mehran M},
  title = {Collagen Hybridizing Peptide–Based Radiotracers for Molecular Imaging of Collagen Turnover in Pulmonary Fibrosis},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.268832}
}
Kostenlos starten →